mNexspike
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mNexspike, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: EMA Authorised: mNexspike (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding the N-terminal domain and receptor-binding domain of the viral spike (S) protein of SARS-CoV-2) — Moderna Biotech Spain, S.L.